Industry Praises MDUFMA Progress, FDA Frets About Meeting Deadline

Devices & Diagnostics Letter
The device industry and the FDA are closer to an agreement on reauthorizing the Medical Device User Fee Amendments Act (MDUFMA), but chances are slim that the agency will meet the Jan. 15 goal to delivery that agreement to Congress.

To View This Article:


Buy This Article Now

Add this article to your cart for $25.00